MARÍA ARANZAZU AIS LARISGOITIA-rekin lankidetzan egindako argitalpenak (8)

2024

  1. Perceived quality of life by patients with immune-mediated inflammatory diseases treated with biological therapies. SACVINFA study

    Farmacia Hospitalaria

2022

  1. Design and implementation of a mobile app for the pharmacotherapeutic follow-up of patients diagnosed with immune-mediated inflammatory diseases: eMidCare

    Frontiers in Immunology, Vol. 13

  2. Evaluation of the hospital care quality perceived by patients with immune-mediated inflammatory diseases from the pharmacy service. SACVINFA study

    Journal of Clinical Pharmacy and Therapeutics, Vol. 47, Núm. 12, pp. 2020-2029

  3. Implementation and evaluation of a home pharmaceutical care model through Telepharmacy

    Farmacia Hospitalaria, Vol. 46, pp. 36-46

  4. Information and Communication Technologies in Patients With Immune-Mediated Inflammatory Diseases: Cross-sectional Survey

    Journal of medical Internet research, Vol. 24, Núm. 9, pp. e37445

  5. The Characteristics and Functionalities of Mobile Apps Aimed at Patients Diagnosed With Immune-Mediated Inflammatory Diseases: Systematic App Search

    Journal of Medical Internet Research, Vol. 24, Núm. 3

2013

  1. Equipotent doses of pegylated epoetin β (CERA) for the treatment of outcome patients with anemia secondary to chronic kidney disease in clinical practice

    Atencion Farmaceutica, Vol. 15, Núm. 1, pp. 55-58

  2. Permanencia del tratamiento antirretroviral de última generación en la práctica clínica diaria

    Farmacia Hospitalaria, Vol. 37, Núm. 2, pp. 151-155